Earnings Call Insights: Lyft (LYFT) Q1 2026 Management view CEO John Risher said, "This Q1 represented another strong quarter for Lyft," adding that the company delivered "double-digit growth in active riders, gross bookings and adjusted EBITDA year-over-year" and that "Rideshare demand remained healthy" with "double-digit rides growth around peak events like Valentine's Day, Super Bowl Sunday and...
Earnings Call Insights: Lyft (LYFT) Q1 2026 Management view CEO John Risher said, "This Q1 represented another strong quarter for Lyft," adding that the company delivered "double-digit growth in active riders, gross bookings and adjusted EBITDA year-over-year" and that "Rideshare demand remained healthy" with "double-digit rides growth around peak events like Valentine's Day, Super Bowl Sunday and St. Patrick's Day." Risher highlighted share and scale signals, saying, "our share of the U.S. rideshare market has grown from 3 years ago when I joined and has held above that point ever since, but an increase in Q1 over last quarter," and noted, "in March, we delivered our highest ever number of rides in a week." On expansion and AV positioning, Risher said Lyft is "now operating in over 120 countries" and that the company "officially closed this week" its acquisition of Gett’s U.K. business, while also describing progress with Waymo in Nashville, including "the construction of a state-of-the-art AV depot" and adding, "We continue to be extremely bullish about AV's ability to expand our market." CFO Erin Brewer said, "In the first quarter, gross bookings were up 19% and adjusted EBITDA up 25% year-over-year," and added, "Over the last 12 months, we've generated a record $1.12 billion in free cash flow" and "executed our largest quarterly share repurchase ever, totaling $300 million in the quarter." Outlook Brewer tied near-term guidance to accelerating growth, saying, "At the midpoint of our range, we expect gross bookings to accelerate to approximately 20% and adjusted EBITDA to expand by more than 30% year-over-year." Management framed multiple drivers behind expected ride acceleration, with Brewer stating the company is targeting "our overall objective to deliver north of 1 billion rides for the full year" and attributing Q2 seasonality to "the significant seasonal expansion of the bikes business." Compared with the prior quarter’s framing of California benefits arriv...
Earnings Call Insights: Stoke Therapeutics (STOK) Q1 2026 Management View "On today's call, we will review recent progress with our business" and management highlighted a Phase III and launch timeline, with CEO Ian Smith saying Jason Hoitt will discuss planning "as we prepare for a potential U.S. launch in late 2027, early 2028" (CEO & Director Ian Smith). Smith framed new long-term evidence as ce...
Earnings Call Insights: Stoke Therapeutics (STOK) Q1 2026 Management View "On today's call, we will review recent progress with our business" and management highlighted a Phase III and launch timeline, with CEO Ian Smith saying Jason Hoitt will discuss planning "as we prepare for a potential U.S. launch in late 2027, early 2028" (CEO & Director Ian Smith). Smith framed new long-term evidence as central to the story, citing the company’s New England Journal of Medicine publication and saying, "Today, we are sharing an additional year of data now out to 4 years" with "continued durability in seizure reductions and additional improvements in cognition and behavior" (CEO & Director Smith). Smith emphasized Phase III execution speed: "Our Phase III EMPEROR study... is on track to complete enrollment in the U.S., U.K. and Japan in June, just 10 months after the first patient was randomized" and said the Phase III "data readout" is expected "in mid-2027" (CEO & Director Smith). Smith linked regulatory timing to a rolling filing, stating: "These data are expected to complete our rolling NDA submission, which is anticipated to start in Q1 2027" (CEO & Director Smith). CFO Thomas Leggett reported cash and financing activity: "We ended the quarter with $411 million of cash, cash equivalents and marketable securities" and "raised $80.7 million in net proceeds through our ATM program, selling approximately 2.6 million shares of common stock" (Chief Financial Officer Thomas Leggett). CMO Barry Ticho described the 4-year open-label extension (OLE) cohort and retention, stating the data are from "the first 75 people" and "approximately 77% of the patients remain in the studies" (Chief Medical Officer Barry Ticho). Ticho characterized efficacy as durable, citing "median reduction in major motor seizure frequency of 59% to 91%" through month 28 (Chief Medical Officer Ticho). On safety, Ticho said: "Overall, no new safety findings have emerged"; "Elevated CSF protein lab values occurr...
German industrial production unexpectedly fell in March for a second month, adding to worries for Europe’s largest economy as it grapples with the Iran war. Output dropped 0.7% from February, driven by declines in energy and machinery and equipment manufacturing, the German statistics office said Friday. Most economists surveyed by Bloomberg had predicted an increase. Separately, exports rose 0.5%...
German industrial production unexpectedly fell in March for a second month, adding to worries for Europe’s largest economy as it grapples with the Iran war. Output dropped 0.7% from February, driven by declines in energy and machinery and equipment manufacturing, the German statistics office said Friday. Most economists surveyed by Bloomberg had predicted an increase. Separately, exports rose 0.5% in March, while imports surged 5.1%, mostly because of goods shipped from China. While the data cover the first month of the Middle East conflict, they suggest some underlying weakness even before the full impact of the war hit industry, with energy-intensive companies still showing increases in production. Higher oil and natural gas prices as well as the persistent uncertainty surrounding the fighting are likely to have weighed on business more in the current quarter. The numbers follow a release on Thursday showing factory orders jumped far more than expected in March. The government attributed that increase to front-loading effects. “The renewed decline confirms the general picture that industrial production has been fluctuating sideways at a low level for the past year and a half,” Joerg Kraemer , chief economist at Commerzbank AG in Frankfurt, said in an e-mailed reaction. “Yesterday’s increase in orders will not change this, as it was primarily due to war-related pull-forward effects.” While Germany’s economy expanded by 0.3% in the first quarter, the war looks set to test Chancellor Friedrich Merz ’s promise to turn 2026 into a “year of growth,” adding to tensions between coalition partners. In April, Berlin halved its growth outlook for 2026 to 0.5% — despite a massive ramp-up in spending on infrastructure and defense. Production “slowed noticeably again at the start of 2026 against the backdrop of heightened geopolitical uncertainties,” the Economy Ministry said in an emailed statement. “The conflict in the Middle East is not only driving up prices but is also inc...
J Studios/DigitalVision via Getty Images Corporations are building their own blockchains to capture settlement economics previously flowing to public chains. We examine the $60B+ opportunity. The Rise of Corporate Blockchains: Settlement Goes Onchain, Value Capture Goes In-House Since the beginning of 2025, altcoins like ETH and SOL have fallen by -32% and -57%, while an index of crypto equities (...
J Studios/DigitalVision via Getty Images Corporations are building their own blockchains to capture settlement economics previously flowing to public chains. We examine the $60B+ opportunity. The Rise of Corporate Blockchains: Settlement Goes Onchain, Value Capture Goes In-House Since the beginning of 2025, altcoins like ETH and SOL have fallen by -32% and -57%, while an index of crypto equities (MVDAPPP) is up +48% . The divergence reflects a deeper shift: corporations are capturing the settlement economics that previously flowed to public-chain tokens. Even with a more permissive regulatory environment under a “Bitcoin President,” value is migrating from protocol tokens to the equities and infrastructure providers building corporate blockchains (“corpchains”). L1 Blockchain Tokens Are Down -49% Since the Start of 2025; Crypto Equities +48% Crypto Equities Outperformed L1 Tokens by Nearly 100 Percentage Points Source: Bloomberg as of 5/06/2026. Past performance is not a guarantee of future results. Not intended as a recommendation to buy or sell any securities named herein. Three forces are converging to drive this shift: economic incentives from faster onchain settlement, the GENIUS Act formalizing compliant stablecoin issuance, and direct integration with Federal Reserve rails through new banking charters. Together, they enable corporations to run regulated blockchain settlement systems while bypassing the traditional deposit layer. We unpack each below. One major reason is that stablecoins and real-world asset (RWA) tokenization have achieved some measure of regulatory clarity. Meanwhile, many public blockchain tokens are stuck in an uncomfortable legal limbo in which they can neither provide strong value accrual nor offer important investor protections via a functioning disclosure regime. The competitive landscape has also materially widened to include banks, fintechs, financial entities, and newly public infrastructure providers. Some of these companies even h...
Air India Ltd. is looking to implement measures to cut costs and reduce flights in the wake of the Iran war, people familiar with the matter said, just as the unprofitable airline searches for a new leader to navigate an exceptionally difficult period. Among the measures discussed in a board meeting on Thursday were furloughing nontechnical employees and cutting flight capacity by over 20% for the...
Air India Ltd. is looking to implement measures to cut costs and reduce flights in the wake of the Iran war, people familiar with the matter said, just as the unprofitable airline searches for a new leader to navigate an exceptionally difficult period. Among the measures discussed in a board meeting on Thursday were furloughing nontechnical employees and cutting flight capacity by over 20% for the next three months unless the situation improves, said people with knowledge of the matter who did not want to be identified as the discussions are private. The board also discussed paying out lower bonuses for all employees and pay cuts for those at the level of vice president and above, the people said. The cost-cutting measures at India’s second-largest airline are likely to be announced soon, they added. An Air India representative did not immediately respond to a request for comment. The moves signal the first major sign of distress at an Indian airline since the start of the Iran war, which has roiled the aviation industry worldwide. For Air India, the war compounds its existing struggles following a fatal crash and airspace closures due to the border flare-up with Pakistan last year. The Jet-Fuel Surge Is Making Global Flight Connections Disappear The carrier closed the financial year on March 31 with a record loss of more than 220 billion rupees ($2.3 billion). Singapore Airlines Ltd. , which owns 25.1% of Air India, has seen its earnings dragged down by the losses and as a result is deepening its operational involvement at the carrier. The turmoil also comes as the Tata Group-owned airline is looking for a new chief executive officer to replace Campbell Wilson , who resigned in April. India’s largest carrier IndiGo appointed aviation veteran Willie Walsh as its new CEO at the end of March to steer it through a particularly tough time for the country’s airlines.
Intertek Group Plc rejected the latest takeover offer from EQT AB as the product testing business continues to resist the private equity firm’s advances. EQT’s £58-per-share cash proposal, worth around £8.9 billion ($12 billion) excluding debt, significantly undervalues its future prospects and comes with execution risk, the British company said on Friday . It’s the third time Intertek’s board has...
Intertek Group Plc rejected the latest takeover offer from EQT AB as the product testing business continues to resist the private equity firm’s advances. EQT’s £58-per-share cash proposal, worth around £8.9 billion ($12 billion) excluding debt, significantly undervalues its future prospects and comes with execution risk, the British company said on Friday . It’s the third time Intertek’s board has rejected an offer from EQT, which said earlier this week its latest proposal would deliver “certain and accelerated cash value for shareholders, superior to the range of outcomes associated with Intertek’s standalone prospects.” EQT’s previous proposals were priced at £51.50 and £54 a share. Read More: EQT Raises Bid for UK Testing Firm Intertek to £8.9 Billion Separate to EQT’s pursuit, Intertek has been exploring a breakup to boost its value. The company is examining whether to split its testing and assurance businesses from its energy and infrastructure divisions. Intertek said Friday it’s already received interest from potential buyers of its energy and infrastructure business, which generated £1.59 billion in revenue last year. It’s prioritizing a sale over a demerger but is open to either. Intertek plans to complete and implement the results of its strategic review by the middle of 2027. EQT has until May 14 to announce plans for a firm offer or walk away.
(RTTNews) - Forward Air Corporation (FWRD) reported a narrower first-quarter loss despite a decline in revenue, mainly helped by lower losses from other operations.
(RTTNews) - Forward Air Corporation (FWRD) reported a narrower first-quarter loss despite a decline in revenue, mainly helped by lower losses from other operations.
Earnings Call Insights: Crinetics Pharmaceuticals (CRNX) Q1 2026 Management view "This collective effort has translated into 232 additional patient enrollments and $10.3 million in net product revenue for the quarter," said (Founder, President, CEO & Director R. Struthers), while adding, "we continue to see momentum build on all fronts in the second quarter." Struthers tied early launch execution ...
Earnings Call Insights: Crinetics Pharmaceuticals (CRNX) Q1 2026 Management view "This collective effort has translated into 232 additional patient enrollments and $10.3 million in net product revenue for the quarter," said (Founder, President, CEO & Director R. Struthers), while adding, "we continue to see momentum build on all fronts in the second quarter." Struthers tied early launch execution to longer-term positioning, saying, "Palsonify sets a new standard of care for the treatment of acromegaly and is on track to become the most prescribed brand," and highlighted international regulatory activity: "the European Commission approval of our MAA, the JNDA submission in Japan by our partners at SKK and our MAA submission in Brazil." (Chief Commercial Officer Isabel Kalofonos) described demand mix and prescribing breadth: "the majority of new enrollments continue to come from patients switching from existing therapies," and "treatment-naive patients increased from 5% to 15% of total enrollments" from Q4 2025 to Q1 2026. Kalofonos also pointed to access and payer progress: "approximately 70% of patients on therapy at the end of first quarter were reimbursed," and "we have now achieved over 60% coverage and remain on track to exceed our 75% coverage goal by the end of third quarter of 2026." (Chief Financial Officer Tobin Schilke) framed spending and runway, saying, "we recognized $10.7 million in total revenue," "research and development expenses for the first quarter were $100.1 million," and "we project that our existing cash and investments will be sufficient to fund our operations into 2030." Outlook Schilke said, "we are maintaining our guidance for GAAP and non-GAAP operating expenses in 2026," specifying "GAAP operating expenses to be between $600 million and $650 million" and "non-GAAP operating expenses... to be between $480 million and $520 million." On the commercial trajectory, (CFO Schilke) avoided a form-volume forecast, saying, "it's really tricky to ...